文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

严重大流行 2009 年 H1N1 流感疾病是由致病免疫复合物引起的。

Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes.

机构信息

Fundacion INFANT, Buenos Aires, Argentina.

出版信息

Nat Med. 2011 Feb;17(2):195-9. doi: 10.1038/nm.2262. Epub 2010 Dec 5.


DOI:10.1038/nm.2262
PMID:21131958
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3034774/
Abstract

Pandemic influenza viruses often cause severe disease in middle-aged adults without preexisting comorbidities. The mechanism of illness associated with severe disease in this age group is not well understood. Here we find preexisting serum antibodies that cross-react with, but do not protect against, 2009 H1N1 influenza virus in middle-aged adults. Nonprotective antibody is associated with immune complex-mediated disease after infection. We detected high titers of serum antibody of low avidity for H1-2009 antigen, and low-avidity pulmonary immune complexes against the same protein, in severely ill individuals. Moreover, C4d deposition--a marker of complement activation mediated by immune complexes--was present in lung sections of fatal cases. Archived lung sections from middle-aged adults with confirmed fatal influenza 1957 H2N2 infection revealed a similar mechanism of illness. These observations provide a previously unknown biological mechanism for the unusual age distribution of severe cases during influenza pandemics.

摘要

大流行性流感病毒常导致无潜在合并症的中年成年人发生严重疾病。对于该年龄组中与严重疾病相关的发病机制尚不清楚。在这里,我们发现中年成年人中预先存在的血清抗体与 2009 年 H1N1 流感病毒发生交叉反应,但不能预防该病毒。非保护性抗体与感染后免疫复合物介导的疾病有关。我们在重症患者中检测到针对 H1-2009 抗原的低亲和力血清抗体和针对同一蛋白的低亲和力肺免疫复合物的高滴度。此外,在致命病例的肺组织切片中存在 C4d 沉积——一种由免疫复合物介导的补体激活的标志物。从中年成年人确诊的致死性流感 1957 年 H2N2 感染的存档肺组织切片中揭示了一种类似的发病机制。这些观察结果为流感大流行期间严重病例的异常年龄分布提供了一个以前未知的生物学机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7afc/3034774/dcbc47b252da/nihms247007f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7afc/3034774/57e2694980ac/nihms247007f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7afc/3034774/f6250b26a579/nihms247007f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7afc/3034774/5521a616c173/nihms247007f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7afc/3034774/dcbc47b252da/nihms247007f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7afc/3034774/57e2694980ac/nihms247007f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7afc/3034774/f6250b26a579/nihms247007f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7afc/3034774/5521a616c173/nihms247007f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7afc/3034774/dcbc47b252da/nihms247007f4.jpg

相似文献

[1]
Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes.

Nat Med. 2010-12-5

[2]
Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.

BMC Res Notes. 2015-4-10

[3]
High titer and avidity of nonneutralizing antibodies against influenza vaccine antigen are associated with severe influenza.

Clin Vaccine Immunol. 2012-7

[4]
Cytokine and chemokine profiles in lung tissues from fatal cases of 2009 pandemic influenza A (H1N1): role of the host immune response in pathogenesis.

Am J Pathol. 2013-8-11

[5]
Cross-reactive immunity against influenza viruses in children and adults following 2009 pandemic H1N1 infection.

Antiviral Res. 2015-2

[6]
Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009.

Health Technol Assess. 2010-12

[7]
Age-associated cross-reactive antibody-dependent cellular cytotoxicity toward 2009 pandemic influenza A virus subtype H1N1.

J Infect Dis. 2013-6-28

[8]
Anti-neuraminidase antibodies against pandemic A/H1N1 influenza viruses in healthy and influenza-infected individuals.

PLoS One. 2018-5-9

[9]
Pre-existing immunity with high neutralizing activity to 2009 pandemic H1N1 influenza virus in Shanghai population.

PLoS One. 2013-3-19

[10]
Determination of antibody response to the human pandemic influenza H1N1 2009 among patients with influenza-like illness and high risk groups.

Asian Pac J Allergy Immunol. 2010-3

引用本文的文献

[1]
Anti-pA137R antibodies exacerbate the pathogenicity of African swine fever virus in pigs.

J Virol. 2025-6-17

[2]
The intersection of influenza infection and autoimmunity.

Front Immunol. 2025-4-3

[3]
How Broadly Neutralising Antibodies Are Redefining Immunity to Influenza.

Antibodies (Basel). 2025-1-7

[4]
Antibody Avidity Maturation Following Booster Vaccination with an Intranasal Adenovirus Salnavac Vaccine.

Vaccines (Basel). 2024-12-2

[5]
The role of antibody-dependent enhancement in dengue vaccination.

Trop Dis Travel Med Vaccines. 2024-11-1

[6]
Effect of Mixed Probiotics on Alleviating H1N1 Influenza Infection and Regulating Gut Microbiota.

Foods. 2024-9-27

[7]
Adjuvant Use of the Invariant-Natural-Killer-T-Cell Agonist α-Galactosylceramide Leads to Vaccine-Associated Enhanced Respiratory Disease in Influenza-Vaccinated Pigs.

Vaccines (Basel). 2024-9-18

[8]
Impact of Pre-Existing Immunity and Age on Antibody Responses to Live Attenuated Influenza Vaccine.

Vaccines (Basel). 2024-8-1

[9]
The Phenomenon of Thrombotic Microangiopathy in Cancer Patients.

Int J Mol Sci. 2024-8-21

[10]
Mechanisms of antibody-dependent enhancement of infectious disease.

Nat Rev Immunol. 2025-1

本文引用的文献

[1]
Does Glycosylation as a modifier of Original Antigenic Sin explain the case age distribution and unusual toxicity in pandemic novel H1N1 influenza?

BMC Infect Dis. 2010-1-7

[2]
Streptococcus pneumoniae coinfection is correlated with the severity of H1N1 pandemic influenza.

PLoS One. 2009-12-31

[3]
Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population.

Proc Natl Acad Sci U S A. 2009-11-16

[4]
Lung pathology in fatal novel human influenza A (H1N1) infection.

Am J Respir Crit Care Med. 2009-10-29

[5]
Critical care services and 2009 H1N1 influenza in Australia and New Zealand.

N Engl J Med. 2009-11-12

[6]
Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.

N Engl J Med. 2009-11-12

[7]
In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses.

Nature. 2009-8-20

[8]
Severe respiratory disease concurrent with the circulation of H1N1 influenza.

N Engl J Med. 2009-8-13

[9]
Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico.

N Engl J Med. 2009-8-13

[10]
Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine.

MMWR Morb Mortal Wkly Rep. 2009-5-22

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索